Skip to main content

Table 1 Treatment in present study (n = 23)

From: Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects

Stereotactic body radiation therapy  
Irradiation dose delivered  
 12 Gy × 4 fractions three times per week 11 (47.8%)
 10 Gy × 5 fractions three times per week 9 (39.1%)
 8 Gy × 7 fractions three times per week 3 (13.0%)
Active breathing control 23 (100%)
 Cone-beam CT guiding 23 (100%)
PTV volume (cm 3 )  
 Median 48.4
 Range 26.0-110.2
Lung volume (cm 3 )  
 Total lung (median) 2301.4
   (range) 1983.4-2950.5
 Contralateral lung (median) 1373.4
   (range) 1255.8-1712.3
 Ipsilateral lung (median) 942.2
   (range) 786.8-1233.4
Systematic treatment  
Chemotherapy  
 Concurrent chemotherapy 1 (4.3%)
 Sequential chemotherapy 14 (60.9%)
Tyrosine kinase inhibitor a 3 (13.0%)
None 5 (21.7%)
  1. a: Erlotinib or Gefetinib.